# EaseVRx for the Reduction of Chronic Pain and Opioid Use

> **NCT04139564** · NA · COMPLETED · sponsor: **AppliedVR Inc.** · enrollment: 108 (actual)

## Conditions studied

- Chronic Low-back Pain

## Interventions

- **DEVICE:** EaseVRx headset
- **DEVICE:** Active control VR sham program

## Key facts

- **NCT ID:** NCT04139564
- **Lead sponsor:** AppliedVR Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-11
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2024-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04139564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04139564, "EaseVRx for the Reduction of Chronic Pain and Opioid Use". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04139564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
